Characterization and localization of the endothelin receptors in human end-stage heart failure. ETA/ETB receptor system-Role in the failing human heart

Process Biochemistry

Volumn 44, Issue 6, 2009, Pages 661-667

  Bernal López, M Rosa ^a,e   Rípodas, Ainhoa ^b   Aragoncillo, Paloma ^d   Carbonell, Amparo ^c   Rufilanchas, Juan José ^c   Fernández Durango, Raquel ^b   Tinahones, Francisco J ^a,e   Gómez Huelgas, Ricardo ^a   Fernández Cruz, Arturo ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Atherosclerosis; Atrial appendage; Endothelin system; Heart failure

Indexed keywords

ATHEROSCLEROSIS; ATRIAL APPENDAGE; ENDOTHELIN RECEPTORS; ENDOTHELIN SYSTEM; HEALTHY CONTROLS; HEART FAILURE; HUMAN DISEASE; HUMAN HEARTS; MICROAUTORADIOGRAPHY; RECEPTOR SYSTEMS;

AMINES;

EID: 67349162071     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2009.02.006     Document Type: Article

References (35)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature (Lond) 332 (1988) 411-415
2. Shubeita H.E., McDonough P.M., Harris A.N., Knowlton K.U., Glembotski C.C., Brown J.H., et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265 33 (1990) 20555-20562
3. An S.J., Boyd R., Zhu M., Chapman A., Pimentel D.R., and Wang H.D. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res 75 4 (2007) 702-709
4. Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. Cloning and expression of a cDNA enconding an endothelin receptor. Nature 348 (1990) 730-732
5. A receptor distribution. J Cardiovac Pharmacol 22 Suppl 8 (1993) S128-S131
6. Masaki T., Kimura S., Yanagisawa M., and Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84 4 (1991) 1457-1468
7. Williams D.L., Pettibone K.L., Jones D.J., LisF E.V., and Clinschmidt B.V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175 (1991) 556-561
8. A receptors predominate in the human vasculature and mediate constriction. J Cardiovasc Pharmacol 26 Suppl 3 (1995) S265-S267
9. A sub-type. Br J Pharmacol 114 (1995) 1110-1116
10. Cannan C.R., Burnett Jr. J.C., and Lerman A. Enhanced coronary vasoconstriction to endothelin-B receptor activation in experimental congestive heart failure. Circulation 93 (1996) 646-651
11. Molenaar P., O'Reilly G., Sharkey A., Kuc R.E., Harding D.P., Plumpton C., et al. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72 (1993) 526-538
12. Zaroff JG, Rosengard BR, ArmstrongWF, Babcock WD, D'Alessandro A, William Dec G, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, VA. Circulation 2002;106:836-41.
13. Lowry O., Rosenbrough N., Farr A., and Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
14. Rípodas A., De Juan J., Moya J., Fernández-Cruz A., and Fernández-Durango R. Identification of endothelin receptor subtypes in rat ciliary body using subtype-selective ligands. Exp Eye Res 66 (1998) 69-79
15. Munson P.J., and Rodbard D. LIGAND: to versatile computerized approach for characterization of ligand binding systems. Anal Biochem 107 1 (1980) 220-233
16. MacPherson G.A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J Pharmacol Meth 14 (1985) 213-224
17. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51 (1949) 660-672
18. Neri Serneri G.G., Cecioni I., Vanni S., Paniccia R., Bandinelli B., Vetere A., et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in human failing heart. Circ Res 86 4 (2000) 377-385
19. Miyauchi T., and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Ann Rev Physiol 61 (1999) 391-415
20. Pönike K., Vogelsang M., Heinroth M., Becker K., Zolk O., Bohm M., et al. Endothelin receptors in the failing and nonfailing human heart. Circulation 97 3 (1998) 744-745
21. Brunner F., and Doherty A.M. Role of ETB receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD155080 and BQ-788. FEBS Lett 6396 (1999) 238-242
22. Modesti P.A., Vanni S., Paniccia R., Bandinelli B., Bertolozzi I., Polidori G., et al. Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes. J Cardiovasc Pharmacol 34 (1999) 333-339
23. Hirata Y., Takagi Y., Fukuda Y., and Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78 (1989) 225-228
24. Nishimura J., Chen X., Jahan H., Shikasho T., Kobayashi S., and Kanaide H. cAMP induces upregulation of ETA receptor mRNA and increases responsiveness to endothelin-1 of rat aortic smooth muscle cells in primary culture. Biochem Biophys Res Commun 188 (1992) 719-726
25. Castellanos R., Lobo Marquez L., and Gonzalez S. Fibrilación auricular en pacientes con insuficiencia cardíaca. Rev Fed Arg Cardiol 32 (2003) 351-357
26. Tuinenburg A.E., Van Veldhuisen D.J., Boomsma F., Van Den Berg M.P., De Kam P.J., and Crijns H.J. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol 81 10 (1998) 1207-1210
27. Chen M.C., Wu C.J., Yip H.K., Chang H.W., Chen C.J., Yu T.H., et al. Increased circulating endothelin-1 in rheumatic mitral stenosis: irrelevance to left atrial and pulmonary artery pressures. Chest 125 2 (2004) 390-396
28. Masson S., Gorini M., Salio M., Lucci D., Latini R., and Maggioni A.P. Clinical correlates of elevated plasma natriuretic peptides and big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators. Ital Heart J 1 4 (2000) 282-288
29. Clavell A.L., and Burnett Jr. J.C. The role of endothelin in congestive heart failure. In: Lüsher T.F. (Ed). The endothelium in cardiovascular disease: pathophysiology clinical presentation and pharmacotherapy (1995), Springer 33-42 ISBN: 3-540-59352-7
30. Zarco P. Bases moleculares de la cardiología clínica. Ed. Médica Panamericana; 1996.
31. Neri Serneri G.G., Modesti P.A., Boddi M., Cecioni I., Paniccia R., Coppo M., et al. Cardiac growth factors in human hypertrophy: relations with myocardial contractility and wall stress. Circ Res 85 (1999) 57-67
32. Arai M, Yoguchi A, Iso T, Takahashi T, Imai S, Murata K, et al. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol 1995;268:H2084-91.
33. Yorikane R., Sakai S., Miyauchi T., Sakurai T., Sugishita Y., and Goto K. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett 332 (1993) 31-34
34. Ito H., Adachi S., Tamamori M., Fujisaki H., Tanaka M., Lin M., et al. Mild hipoxia induces hypertrophy of cultures neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J Mol Cell Cardiol 28 (1996) 1271-1277
35. Tonnessen T., Giad A., Saleh D., Naess P.A., Yanagisawa M., and Christensen G. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 76 (1995) 767-772